Page last updated: 2024-12-07
acid violet 17
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
violet BNP: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 92205 |
| SCHEMBL ID | 1395972 |
| MeSH ID | M0099404 |
Synonyms (75)
| Synonym |
|---|
| pontacyl violet c4bn |
| metamine fast violet 4b |
| tertracid milling violet 4b |
| brilliant acid violet 4b |
| sumitomo acid violet 5bn |
| violet 2embl |
| fast acid violet b |
| formyl violet s4b |
| acidal brilliant violet 2b |
| coomassie violet r |
| brilliant milling violet s4b |
| leather violet s4b |
| formyl violet |
| mitsui acid violet 5bn |
| hispacid violet x4bf |
| coomassie lake violet r |
| c.i. acid violet 17, sodium salt |
| acid leather violet b |
| airedale violet 4bns |
| adc acid brilliant milling violet 4bs |
| c.i. food violet 1 |
| acid violet acs |
| solar violet 4bn |
| pontacyl violet s4b |
| c.i. 42650 |
| acidal brilliant violet 6b |
| cetil brilliant violet s4b |
| calcocid violet 4bxn |
| acid violet 4bo |
| acid leather violet 2b |
| naphthalene leather violet r |
| acid violet 17 |
| milling violet s4b |
| erio violet 6bn |
| 4129-84-4 |
| burmese violet 4bo |
| 1942 violet |
| c.i. acid violet 17 |
| acid violet 5bs |
| shimazaki acid violet 5bn |
| violet s4r |
| derma violet 4br |
| violet bnp |
| amacid violet 3b |
| food violet 1 |
| pontacyl violet c4b |
| formyl violet s4ba |
| vondamol violet s4b |
| acid leather violet 3b |
| merantine violet s4b |
| fenazo violet x4b |
| coomassie violet r200, dye content 50 % |
| einecs 223-942-6 |
| nsc 5019 |
| nsc 71963 |
| benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt (1:1) |
| hydrogen (4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt |
| c.i.42581 |
| benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt |
| benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt |
| AKOS015916401 |
| benzenemethanaminium, n-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-n-ethyl-3-sulfo-, inner salt, sodium salt |
| SCHEMBL1395972 |
| acidviolet17 |
| hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulp honatobenzyl)ammonium na salt |
| W-109953 |
| DTXSID1041635 |
| acid violet 17 (c.i. 42650) |
| mfcd00012120 |
| sodium (z)-3-(((4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dienylidene)(ethyl)ammonio)methyl)benzenesulfonate |
| benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt (9ci) |
| sodium;3-[[4-[[4-(diethylamino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate |
| serva violet 17 |
| 1313437-37-4 |
| sodium 3-(((4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)ammonio)methyl)benzenesulfonate |
Research Excerpts
Effects
| Excerpt | Reference | Relevance |
|---|---|---|
| "Acid violet 17 (AV17) has recently received CE certification as a dye for intraocular use during vitreoretinal interventions. " | ( Acid Violet 17: a New Dye for Chromovitrectomy? Gerding, H, 2016) | 3.32 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (19)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 27.92
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.92) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (5.26%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 18 (94.74%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||